Peripheral Artery Disease
Peripheral Artery Disease (PAD) is a vascular disorder characterized by the narrowing of arteries, most commonly in the legs and feet, due to atherosclerosis, resulting in reduced blood flow to these areas. This condition affects arteries that carry blood away from the heart to other body parts, excluding those that supply the heart or brain.
Health Outcomes
- Changed Walking Cadence
- Delayed Cardiac Pathology
- Enhanced Folate Synthesis
- Enhanced Wound Healing
- Improved 6-Meter Walk Performance
- Improved 6-minute Walking Distance
- Improved Aerobic Endurance Performance
- Improved Anaerobic Power
- Improved Angiogenesis
- Improved Auto-Aggregation Capability
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Cutaneous Blood Flow
- Improved Diabetic Foot Ulcer Healing
- Improved Distance Traveled
- Improved Endothelial Function Biomarker
- Improved Endothelial Health Marker Level
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation
- Improved Endothelium-Independent Microvascular Vasodilation
- Improved Exercise Endurance
- Improved Exercise Function
- Improved Exercise Tolerance
- Improved Fibrinolytic Activity
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Functional Exercise Capacity
- Improved Intermittent Exercise Performance
- Improved Lactate Threshold
- Improved Leg Press Performance
- Improved Limited Distance Test Performance
- Improved Lower Limb Peak Power
- Improved Maximal Exercise Capacity
- Improved Maximal Oxygen Consumption
- Improved Maximal Walking Performance
- Improved Mean Arterial Pressure
- Improved Microvascular Vasodilation
- Improved Muscle Oxygen Flux
- Improved Pain-Free Walking Distance
- Improved Peripheral Vascular Function
- Improved Physical Work Capacity
- Improved Reactive Hyperemia Index
- Improved Run Time
- Improved Six-Minute Walk Test
- Improved Stress-Strain Index
- Improved Vascular Function
- Improved Vascular Function in Offspring
- Improved Vasodilation
- Improved Walking Ability
- Improved Walking Distance
- Improved Walking Speed
- Increased Angiogenesis
- Increased Arginine/ADMA Ratio
- Increased Endothelial Nitric Oxide Synthase Activity
- Increased Endothelial Progenitor Cell Count
- Increased Exercise Capacity
- Increased Nitric Oxide Bioavailability
- Increased Plasma Nitric Oxide Levels
- Increased Shear Force
- Increased Walking Speed
- No Change in Major Cardiovascular Event
- Reduced Anaerobic Lactic Energy
- Reduced Angiogenesis
- Reduced Aortic Superoxide Levels
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Arterial Stiffness
- Reduced Atherogenic Index
- Reduced Atherosclerosis Risk Factors
- Reduced Atherosclerotic Cardiovascular Disease Event
- Reduced Atherosclerotic Plaque Formation
- Reduced Cadence
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Event
- Reduced Cardiovascular Mortality
- Reduced Central Blood Pressure
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced Debridement Time
- Reduced HDL Cholesterol
- Reduced HMG-CoA Reductase Inhibition
- Reduced Incidence of Footpad Lesions
- Reduced Intimal Thickening
- Reduced Leg Adiposity
- Reduced Monocyte Adhesion
- Reduced Plaque
- Reduced Platelet Function Marker Level
- Reduced Skin Sensitivity
- Reduced Thrombosis
- Reduced Thromboxane A2 Level
- Reduced Time Trial Completion Time
- Reduced Ulcer Size
- Reduced Vascular Damage
- Reduced Vascular Restenosis
- Reduced Walking Time
- Reduced Wound Area